4Accepted Sep 21, 3:13 PM ET
Pharvaris (PHVS) Chief Early Development Anne Lesage Sells 20,000 Shares
Accepted (ET)
3:13 PM
Sep 21, 2026
Filed
Sep 21, 2026
Documents
1
Size
6.2 KB
Summary
Pharvaris (PHVS) Chief Early Development Anne Lesage Sells 20,000 Shares
What Happened
- Anne Lesage, Chief Early Development at Pharvaris N.V. (PHVS), sold 20,000 shares on 2026-09-17. The reported weighted-average sale price was $38.27, for total proceeds of approximately $765,466. The sale was carried out in connection with the exercise of stock options via a cashless exercise (the shares were sold upon exercise).
Key Details
- Transaction date: 2026-09-17; weighted-average price $38.27 (individual sale prices ranged $38.04–$38.65). (F1)
- Total shares sold: 20,000; gross proceeds ≈ $765,466.
- Shares owned after transaction: not specified in the provided excerpt.
- Footnotes: F1 explains the weighted-average price, sale range, and that the sales were part of a cashless option exercise; the reporting person can provide per-price breakdown on request. F2 notes GrayMatters Consulting B.V. is an entity controlled by Dr. Lesage.
- Filing timing: Report filed 2026-09-21 for a 2026-09-17 transaction (filed within the typical two-business-day Form 4 window).
Context
- This was an option exercise with immediate sale (cashless exercise), which is a common way for insiders to cover option costs and taxes. Sales are often routine and do not necessarily indicate a change in sentiment; purchases are generally more informative about insider conviction.